8th ISAP Symposium
Developments in Pharmacokinetics and Pharmacodynamics (PK/PD):
optimizing efficacy and prevention of resistance
Nijmegen, The Netherlands, July 4th-6th, 2001

Can PK/PD be used in everyday clinical practice?

 

Click here to start

Table of Contents

PPT Slide

PK/PD results and evolution

Several objectives

PK/PD evolution

PPT Slide

Optimizing antimicrobial therapy

PHARMACODYNAMICS

Improving the probability of positive outcomes

PK/PD parameters determining efficacy

Peak level of tobramycin 3mg/kg in ten patients in ICU

PPT Slide

PPT Slide

PPT Slide

PPT Slide

Ideal approach to adjust the dose

First problem PK approach to adjust the dose is poor applicable for routinely use (at moment)

second problem PK/PD breakpoints

Program to customize the therapy in our hospital

PK/PD values adopted

Sampling time

Concentrations of ceftazidime and cefotaxime in serum

Peak levels of amikacin

PPT Slide

preliminary results

diagnosis

Organisms isolated

Aminoglicosides Dose adjusted according to creatinine clearance

Ceftazidime-Cefotaxime-Levofloxacin Dose adjusted according to creatinine clearance

Ciprofloxacin Dose adjusted according to creatinine clearance

outcome

PPT Slide

Conclusions I

Conclusions II

PPT Slide

Conclusions IV homework

Author: F. Scaglione 

Email: webmaster@isap.org

Home Page: http://www.isap.org/slides.htm

Important note:

These slides are for information only. Do not make public use of them without autorization of the author and the ISAP Webmaster 

Download presentation as PDF file